USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Genome Sequencing Market By Type (Products and Services), By Technology (Polymerase Chain Reaction (PCR), Sanger Sequencing, Non-Sanger’s Sequencing, Microarray, and Next-Generation Sequencing (NGS)), By Application (Diagnostic, Research, and Others), By End-User (Healthcare Facilities & Diagnostic Centers, Research Institutes, and Pharmaceutical & Biotechnological Companies), And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2026

Covid-19

Genome Sequencing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[227+ Pages Report] According to Facts & Factors, the “Global Genome Sequencing Market” report clarifies the complete market overview and breakdown structure. In this report, the global genome sequencing market witnessed a value of USD 27 Billion by 2020 and with growth at a CAGR of 20% is projected to reach a value of USD 95 Billion by 2026.

logoMarket Overview

Genome sequencing is a technology that refers to the sequencing of the entire organism. This technique helps figure out the entire sequence or order of the DNA nucleotides/bases which includes the order of As, Cs, Gs, and Ts that form the backbone of an organism's DNA. In the human genome, there are around 3 billion genetic letters. The hi-end machines are used to read and sequence the genomes. Genome sequencing helps in the discovery of biomarkers, study of personalized medication, oncology studies, forensics, and others. In healthcare, there is a shift from conventional methods to precision medicines with the help of genomics. Currently, the most useful tool is whole-genome sequencing.

The rise in R&D activities and the increasing number of genome mapping programs across the globe are projected to propel the global genome sequencing market. The development of tools such as Neoantigen Presentation Score (NEOPS) is one of the major factors contributing to the industry growth.

logoIndustry Growth Factors

The growing demand for the prevention, treatment, and management of diseases is anticipated to boost the demand for genome sequencing over the forecast period. Additionally, the rising investments in research and advancements in the field of bioinformatics will further escalate market growth. The sudden onset of the COVID-19 pandemic has urged healthcare facilities, biotechnology companies, and the government to invest in research activities related to the development of vaccines or novel treatments. Moreover, the positive potentials of genome sequencing have encouraged start-ups to provide sequencing services for further application in genetic diseases, ancestry, and others.

The major factor contributing to the genome sequencing industry is the rising number of government genome projects such as the Personalized Medicine Programme, Saudi Human Genome Program, etc. The introduction of NGS has helped shift to personalized medicines and also reduce the cost of sequencing. However, the lack of awareness, high-costing tools, and shortage of skilled technicians are likely to hinder the genome sequencing market growth.

Genome Sequencing Market

logoSegmentation Analysis

The global genome sequencing market is segmented based on type, technology, application, end-user, and regions.

Based on type, the global genome sequencing market is divided into products and services. The product segment is projected to hold the largest market share over the forecast period. The growth is primarily due to the rising demand, utilization of consumables, and launch of new automated products & software. On the basis of technology, the market is categorized into polymerase chain reaction (PCR), Sanger sequencing, Non-Sanger’s sequencing, microarray, and next-generation sequencing (NGS). From these, the polymerase chain reaction (PCR) accounts for the largest market share in the global genome sequencing market due to its growing use and easy availability across the globe. By application, the genome sequencing market is classified into diagnostic, research, and others. The diagnostic segment accounts for the highest market share.

The dominance is majorly contributed to the rising use of NGS technology by clinical diagnostics and the rising demand for direct-to-consumer genetic testing. Additionally, the growing popularity of nutrigenomics for providing diet plans considering the diseases depending on the patients’ genes is likely to bolster the market growth over the forecast period. Based on end-user, the market is segmented into healthcare facilities & diagnostic centers, research institutes, and pharmaceutical & biotechnological companies. The research institutes segment is expected to dominate the global genome sequencing market due to the increasing government funding and support in the research field.

logo Report Scope

Report Attribute

Details

Market Size in 2020

USD 27 Billion

Projected Market Size in 2026

USD 95 Billion

CAGR Growth Rate

20% CAGR

Base Year

2020

Forecast Years

2021-2026

Key Market Players

Illumina, Inc., BGI, IntegraGen, Bio-Rad Laboratories, QIAGEN, Danaher, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, and Others

Key Segment

By Type, By Technology, By Application, By End-User, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logo Regional Analysis

North America is expected to dominate the global genome sequencing market due to the increasing adoption of sequencing technologies and the growing demand for personalized medicines in this region. Moreover, the launch of Ancestryhealth, a next-generation sequencing technology to identify the blood disorder, colon cancer, breast cancer, and heart diseases related genes in this region will further propel the market over the forecast period. The Asia Pacific is anticipated to exhibit the highest growth rate due to the rising demand for sequencing and testing of genes in China.

logo Competitive Players

Some of the key players participating in the global genome sequencing market include Illumina, Inc., BGI, IntegraGen, Bio-Rad Laboratories, QIAGEN, Danaher, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, Genome Electric Company, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd., among others.

logo By Type Segment Analysis

  • Products
    • Instruments & Software
    • Consumables
  • Services

logo By Technology Segment Analysis

  • Polymerase Chain Reaction (PCR)
  • Sanger Sequencing
  • Non-Sanger’s Sequencing
  • Microarray
  • Next-Generation Sequencing (NGS)

logo By Application Segment Analysis

  • Diagnostic
  • Research
  • Others

logo By End-User Segment Analysis

  • Healthcare Facilities & Diagnostic Centers
  • Research Institutes
  • Pharmaceutical & Biotechnological Companies

logo By Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Covid-19

Genome Sequencing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Genome Sequencing
    2. 1.2. Global Genome Sequencing Market, 2019 & 2026 (USD Billion)
    3. 1.3. Global Genome Sequencing Market, 2016 – 2026 (USD Billion)
    4. 1.4. Global Genome Sequencing Market Absolute Revenue Opportunity, 2016 – 2026 (USD Billion)
    5. 1.5. Global Genome Sequencing Market Incremental Revenue Opportunity, 2020 – 2026 (USD Billion)
  2. Chapter 2 Genome Sequencing Market – Type Analysis
    1. 2.1. Global Genome Sequencing Market – Type Overview
    2. 2.2. Global Genome Sequencing Market Share, by Type, 2019 & 2026 (USD Billion)
    3. 2.3. Product
      1. 2.3.1. Global Product Genome Sequencing Market, 2016 – 2026 (USD Billion)
    4. 2.4. Services
      1. 2.4.1. Global Services Genome Sequencing Market, 2016 – 2026 (USD Billion)
  3. Chapter 3 Genome Sequencing Market – Technology Analysis
    1. 3.1. Global Genome Sequencing Market – Technology Overview
    2. 3.2. Global Genome Sequencing Market Share, by Technology, 2019 & 2026 (USD Billion)
    3. 3.3. Polymerase Chain Reaction (PCR)
      1. 3.3.1. Global Polymerase Chain Reaction (PCR) Genome Sequencing Market, 2016 – 2026 (USD Billion)
    4. 3.4. Sanger Sequencing
      1. 3.4.1. Global Sanger Sequencing Genome Sequencing Market, 2016 – 2026 (USD Billion)
    5. 3.5. Non-Sanger’s Sequencing
      1. 3.5.1. Global Non-Sanger’s Sequencing Genome Sequencing Market, 2016 – 2026 (USD Billion)
    6. 3.6. Microarray
      1. 3.6.1. Global Microarray Genome Sequencing Market, 2016 – 2026 (USD Billion)
    7. 3.7. Next-Generation Sequencing (NGS)
      1. 3.7.1. Global Next-Generation Sequencing (NGS) Genome Sequencing Market, 2016 – 2026 (USD Billion)
  4. Chapter 4 Genome Sequencing Market – Application Analysis
    1. 4.1. Global Genome Sequencing Market – Application Overview
    2. 4.2. Global Genome Sequencing Market Share, by Application, 2019 & 2026 (USD Billion)
    3. 4.3. Diagnostic
      1. 4.3.1. Global Diagnostic Genome Sequencing Market, 2016 – 2026 (USD Billion)
    4. 4.4. Research
      1. 4.4.1. Global Research Genome Sequencing Market, 2016 – 2026 (USD Billion)
    5. 4.5. Others
      1. 4.5.1. Global Others Genome Sequencing Market, 2016 – 2026 (USD Billion)
  5. Chapter 5 Genome Sequencing Market – End-User Analysis
    1. 5.1. Global Genome Sequencing Market – End-User Overview
    2. 5.2. Global Genome Sequencing Market Share, by End-User, 2019 & 2026 (USD Billion)
    3. 5.3. Healthcare Facilities & Diagnostic Centers
      1. 5.3.1. Global Healthcare Facilities & Diagnostic Centers Genome Sequencing Market, 2016 – 2026 (USD Billion)
    4. 5.4. Research Institutes
      1. 5.4.1. Global Research Institutes Genome Sequencing Market, 2016 – 2026 (USD Billion)
    5. 5.5. Pharmaceutical & Biotechnological Companies
      1. 5.5.1. Global Pharmaceutical & Biotechnological Companies Genome Sequencing Market, 2016 – 2026 (USD Billion)
  6. Chapter 6 Genome Sequencing Market – Regional Analysis
    1. 6.1. Global Genome Sequencing Market Regional Overview
    2. 6.2. Global Genome Sequencing Market Share, by Region, 2019 & 2026 (USD Billion)
    3. 6.3. North America
      1. 6.3.1. North America Genome Sequencing Market, 2016 – 2026 (USD Billion)
        1. 6.3.1.1. North America Genome Sequencing Market, by Country, 2016 - 2026 (USD Billion)
      2. 6.3.2. North America Genome Sequencing Market, by Type, 2016 – 2026
        1. 6.3.2.1. North America Genome Sequencing Market, by Type, 2016 – 2026 (USD Billion)
      3. 6.3.3. North America Genome Sequencing Market, by Technology, 2016 – 2026
        1. 6.3.3.1. North America Genome Sequencing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 6.3.4. North America Genome Sequencing Market, by Application, 2016 – 2026
        1. 6.3.4.1. North America Genome Sequencing Market, by Application, 2016 – 2026 (USD Billion)
      5. 6.3.5. North America Genome Sequencing Market, by End-User, 2016 – 2026
        1. 6.3.5.1. North America Genome Sequencing Market, by End-User, 2016 – 2026 (USD Billion)
      6. 6.3.6. U.S.
        1. 6.3.6.1. U.S. Genome Sequencing Market, 2016 – 2026 (USD Billion)
      7. 6.3.7. Canada
        1. 6.3.7.1. Canada Genome Sequencing Market, 2016 – 2026 (USD Billion)
    4. 6.4. Europe
      1. 6.4.1. Europe Genome Sequencing Market, 2016 – 2026 (USD Billion)
        1. 6.4.1.1. Europe Genome Sequencing Market, by Country, 2016 - 2026 (USD Billion)
      2. 6.4.2. Europe Genome Sequencing Market, by Type, 2016 – 2026
        1. 6.4.2.1. Europe Genome Sequencing Market, by Type, 2016 – 2026 (USD Billion)
      3. 6.4.3. Europe Genome Sequencing Market, by Technology, 2016 – 2026
        1. 6.4.3.1. Europe Genome Sequencing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 6.4.4. Europe Genome Sequencing Market, by Application, 2016 – 2026
        1. 6.4.4.1. Europe Genome Sequencing Market, by Application, 2016 – 2026 (USD Billion)
      5. 6.4.5. Europe Genome Sequencing Market, by End-User, 2016 – 2026
        1. 6.4.5.1. Europe Genome Sequencing Market, by End-User, 2016 – 2026 (USD Billion)
      6. 6.4.6. Germany
        1. 6.4.6.1. Germany Genome Sequencing Market, 2016 – 2026 (USD Billion)
      7. 6.4.7. France
        1. 6.4.7.1. France Genome Sequencing Market, 2016 – 2026 (USD Billion)
      8. 6.4.8. U.K.
        1. 6.4.8.1. U.K. Genome Sequencing Market, 2016 – 2026 (USD Billion)
      9. 6.4.9. Italy
        1. 6.4.9.1. Italy Genome Sequencing Market, 2016 – 2026 (USD Billion)
      10. 6.4.10. Spain
        1. 6.4.10.1. Spain Genome Sequencing Market, 2016 – 2026 (USD Billion)
      11. 6.4.11. Rest of Europe
        1. 6.4.11.1. Rest of Europe Genome Sequencing Market, 2016 – 2026 (USD Billion)
    5. 6.5. Asia Pacific
      1. 6.5.1. Asia Pacific Genome Sequencing Market, 2016 – 2026 (USD Billion)
        1. 6.5.1.1. Asia Pacific Genome Sequencing Market, by Country, 2016 - 2026 (USD Billion)
      2. 6.5.2. Asia Pacific Genome Sequencing Market, by Type, 2016 – 2026
        1. 6.5.2.1. Asia Pacific Genome Sequencing Market, by Type, 2016 – 2026 (USD Billion)
      3. 6.5.3. Asia Pacific Genome Sequencing Market, by Technology, 2016 – 2026
        1. 6.5.3.1. Asia Pacific Genome Sequencing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 6.5.4. Asia Pacific Genome Sequencing Market, by Application, 2016 – 2026
        1. 6.5.4.1. Asia Pacific Genome Sequencing Market, by Application, 2016 – 2026 (USD Billion)
      5. 6.5.5. Asia Pacific Genome Sequencing Market, by End-User, 2016 – 2026
        1. 6.5.5.1. Asia Pacific Genome Sequencing Market, by End-User, 2016 – 2026 (USD Billion)
      6. 6.5.6. China
        1. 6.5.6.1. China Genome Sequencing Market, 2016 – 2026 (USD Billion)
      7. 6.5.7. Japan
        1. 6.5.7.1. Japan Genome Sequencing Market, 2016 – 2026 (USD Billion)
      8. 6.5.8. India
        1. 6.5.8.1. India Genome Sequencing Market, 2016 – 2026 (USD Billion)
      9. 6.5.9. South Korea
        1. 6.5.9.1. South Korea Genome Sequencing Market, 2016 – 2026 (USD Billion)
      10. 6.5.10. South-East Asia
        1. 6.5.10.1. South-East Asia Genome Sequencing Market, 2016 – 2026 (USD Billion)
      11. 6.5.11. Rest of Asia Pacific
        1. 6.5.11.1. Rest of Asia Pacific Genome Sequencing Market, 2016 – 2026 (USD Billion)
    6. 6.6. Latin America
      1. 6.6.1. Latin America Genome Sequencing Market, 2016 – 2026 (USD Billion)
        1. 6.6.1.1. Latin America Genome Sequencing Market, by Country, 2016 - 2026 (USD Billion)
      2. 6.6.2. Latin America Genome Sequencing Market, by Type, 2016 – 2026
        1. 6.6.2.1. Latin America Genome Sequencing Market, by Type, 2016 – 2026 (USD Billion)
      3. 6.6.3. Latin America Genome Sequencing Market, by Technology, 2016 – 2026
        1. 6.6.3.1. Latin America Genome Sequencing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 6.6.4. Latin America Genome Sequencing Market, by Application, 2016 – 2026
        1. 6.6.4.1. Latin America Genome Sequencing Market, by Application, 2016 – 2026 (USD Billion)
      5. 6.6.5. Latin America Genome Sequencing Market, by End-User, 2016 – 2026
        1. 6.6.5.1. Latin America Genome Sequencing Market, by End-User, 2016 – 2026 (USD Billion)
      6. 6.6.6. Brazil
        1. 6.6.6.1. Brazil Genome Sequencing Market, 2016 – 2026 (USD Billion)
      7. 6.6.7. Mexico
        1. 6.6.7.1. Mexico Genome Sequencing Market, 2016 – 2026 (USD Billion)
      8. 6.6.8. Rest of Latin America
        1. 6.6.8.1. Rest of Latin America Genome Sequencing Market, 2016 – 2026 (USD Billion)
    7. 6.7. The Middle-East and Africa
      1. 6.7.1. The Middle-East and Africa Genome Sequencing Market, 2016 – 2026 (USD Billion)
        1. 6.7.1.1. The Middle-East and Africa Genome Sequencing Market, by Country, 2016 - 2026 (USD Billion)
      2. 6.7.2. The Middle-East and Africa Genome Sequencing Market, by Type, 2016 – 2026
        1. 6.7.2.1. The Middle-East and Africa Genome Sequencing Market, by Type, 2016 – 2026 (USD Billion)
      3. 6.7.3. The Middle-East and Africa Genome Sequencing Market, by Technology, 2016 – 2026
        1. 6.7.3.1. The Middle-East and Africa Genome Sequencing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 6.7.4. The Middle-East and Africa Genome Sequencing Market, by Application, 2016 – 2026
        1. 6.7.4.1. The Middle-East and Africa Genome Sequencing Market, by Application, 2016 – 2026 (USD Billion)
      5. 6.7.5. The Middle-East and Africa Genome Sequencing Market, by End-User, 2016 – 2026
        1. 6.7.5.1. The Middle-East and Africa Genome Sequencing Market, by End-User, 2016 – 2026 (USD Billion)
      6. 6.7.6. GCC Countries
        1. 6.7.6.1. GCC Countries Genome Sequencing Market, 2016 – 2026 (USD Billion)
      7. 6.7.7. South Africa
        1. 6.7.7.1. South Africa Genome Sequencing Market, 2016 – 2026 (USD Billion)
      8. 6.7.8. Rest of Middle-East Africa
        1. 6.7.8.1. Rest of Middle-East Africa Genome Sequencing Market, 2016 – 2026 (USD Billion)
  7. Chapter 7 Genome Sequencing Market – Competitive Landscape
    1. 7.1. Competitor Market Share – Revenue
    2. 7.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 7.3. Strategic Developments
      1. 7.3.1. Acquisitions and Mergers
      2. 7.3.2. New Products
      3. 7.3.3. Research & Development Activities
  8. Chapter 8 Company Profiles
    1. 8.1. Illumina Inc.
      1. 8.1.1. Company Overview
      2. 8.1.2. Product/Service Portfolio
      3. 8.1.3. Illumina Inc. Sales, Revenue, and Gross Margin
      4. 8.1.4. Illumina Inc. Revenue and Growth Rate
      5. 8.1.5. Illumina Inc. Market Share
      6. 8.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 8.2. BGI
      1. 8.2.1. Company Overview
      2. 8.2.2. Product/Service Portfolio
      3. 8.2.3. BGI Sales, Revenue, and Gross Margin
      4. 8.2.4. BGI Revenue and Growth Rate
      5. 8.2.5. BGI Market Share
      6. 8.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 8.3. IntegraGen
      1. 8.3.1. Company Overview
      2. 8.3.2. Product/Service Portfolio
      3. 8.3.3. IntegraGen Sales, Revenue, and Gross Margin
      4. 8.3.4. IntegraGen Revenue and Growth Rate
      5. 8.3.5. IntegraGen Market Share
      6. 8.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 8.4. Bio-Rad Laboratories
      1. 8.4.1. Company Overview
      2. 8.4.2. Product/Service Portfolio
      3. 8.4.3. Bio-Rad Laboratories Sales, Revenue, and Gross Margin
      4. 8.4.4. Bio-Rad Laboratories Revenue and Growth Rate
      5. 8.4.5. Bio-Rad Laboratories Market Share
      6. 8.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 8.5. QIAGEN
      1. 8.5.1. Company Overview
      2. 8.5.2. Product/Service Portfolio
      3. 8.5.3. QIAGEN Sales, Revenue, and Gross Margin
      4. 8.5.4. QIAGEN Revenue and Growth Rate
      5. 8.5.5. QIAGEN Market Share
      6. 8.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 8.6. Danaher
      1. 8.6.1. Company Overview
      2. 8.6.2. Product/Service Portfolio
      3. 8.6.3. Danaher Sales, Revenue, and Gross Margin
      4. 8.6.4. Danaher Revenue and Growth Rate
      5. 8.6.5. Danaher Market Share
      6. 8.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 8.7. Pacific Biosciences of California Inc.
      1. 8.7.1. Company Overview
      2. 8.7.2. Product/Service Portfolio
      3. 8.7.3. Pacific Biosciences of California Inc. Sales, Revenue, and Gross Margin
      4. 8.7.4. Pacific Biosciences of California Inc. Revenue and Growth Rate
      5. 8.7.5. Pacific Biosciences of California Inc. Market Share
      6. 8.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 8.8. Oxford Nanopore Technologies
      1. 8.8.1. Company Overview
      2. 8.8.2. Product/Service Portfolio
      3. 8.8.3. Oxford Nanopore Technologies Sales, Revenue, and Gross Margin
      4. 8.8.4. Oxford Nanopore Technologies Revenue and Growth Rate
      5. 8.8.5. Oxford Nanopore Technologies Market Share
      6. 8.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 8.9. Genome Electric Company
      1. 8.9.1. Company Overview
      2. 8.9.2. Product/Service Portfolio
      3. 8.9.3. Genome Electric Company Sales, Revenue, and Gross Margin
      4. 8.9.4. Genome Electric Company Revenue and Growth Rate
      5. 8.9.5. Genome Electric Company Market Share
      6. 8.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 8.10. Agilent Technologies Inc.
      1. 8.10.1. Company Overview
      2. 8.10.2. Product/Service Portfolio
      3. 8.10.3. Agilent Technologies Inc. Sales, Revenue, and Gross Margin
      4. 8.10.4. Agilent Technologies Inc. Revenue and Growth Rate
      5. 8.10.5. Agilent Technologies Inc. Market Share
      6. 8.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 8.11. Thermo Fisher Scientific Inc.
      1. 8.11.1. Company Overview
      2. 8.11.2. Product/Service Portfolio
      3. 8.11.3. Thermo Fisher Scientific Inc. Sales, Revenue, and Gross Margin
      4. 8.11.4. Thermo Fisher Scientific Inc. Revenue and Growth Rate
      5. 8.11.5. Thermo Fisher Scientific Inc. Market Share
      6. 8.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
      7. 8.12. F. Hoffmann-La Roche Ltd.
      8. 8.12.1. Company Overview
      9. 8.12.2. Product/Service Portfolio
        1. 8.12.3. F. Hoffmann-La Roche Ltd. Sales, Revenue, and Gross Margin
        2. 8.12.4. F. Hoffmann-La Roche Ltd. Revenue and Growth Rate
        3. 8.12.5. F. Hoffmann-La Roche Ltd. Market Share
      10. 8.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  9. Chapter 9 Genome Sequencing — Industry Analysis
    1. 9.1. Introduction and Taxonomy
    2. 9.2. Genome Sequencing Market – Key Trends
      1. 9.2.1. Market Drivers
      2. 9.2.2. Market Restraints
      3. 9.2.3. Market Opportunities
    3. 9.3. Value Chain Analysis
    4. 9.4. Key Mandates and Regulations
    5. 9.5. Technology Roadmap and Timeline
    6. 9.6. Genome Sequencing Market – Attractiveness Analysis
      1. 9.6.1. By Type
      2. 9.6.2. By Technology
      3. 9.6.3. By Application
      4. 9.6.4. By End-User
      5. 9.6.5. By Region
  10. Chapter 10 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 10.1. Genome Sequencing Industrial Chain Analysis
    2. 10.2. Downstream Buyers
    3. 10.3. Distributors/Traders List
  11. Chapter 11 Marketing Strategy Analysis
    1. 11.1. Marketing Channel
    2. 11.2. Direct Marketing
    3. 11.3. Indirect Marketing
    4. 11.4. Marketing Channel Development Trends
    5. 11.5. Economic/Political Environmental Change
  12. Chapter 12 Report Conclusion & Key Insights
    1. 12.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 12.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  13. Chapter 13 Research Approach & Methodology
    1. 13.1. Report Description
    2. 13.2. Research Scope
    3. 13.3. Research Methodology
      1. 13.3.1. Secondary Research
      2. 13.3.2. Primary Research
      3. 13.3.3. Statistical Models
        1. 13.3.3.1. Company Share Analysis Model
        2. 13.3.3.2. Revenue Based Modeling
      4. 13.3.4. Research Limitations

      List of Figures

      FIG.1	PRODUCT PICTURE OF GENOME SEQUENCING
      FIG.2	GLOBAL GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.3	GLOBAL GENOME SEQUENCING MARKET ABSOLUTE REVENUE OPPORTUNITY, 2016 – 2026 (USD BILLION)
      FIG.4	GLOBAL GENOME SEQUENCING MARKET INCREMENTAL REVENUE OPPORTUNITY, 2020 – 2026 (USD BILLION)
      FIG.5	GLOBAL GENOME SEQUENCING MARKET SHARE, BY TYPE, 2019 & 2026 (USD BILLION)
      FIG.6	GLOBAL PRODUCT GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.7	GLOBAL SERVICES GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.8	GLOBAL GENOME SEQUENCING MARKET SHARE, BY TECHNOLOGY, 2019 & 2026 (USD BILLION)
      FIG.9	GLOBAL POLYMERASE CHAIN REACTION (PCR) GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.10	GLOBAL SANGER SEQUENCING GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.11	GLOBAL NON-SANGER’S SEQUENCING GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.12	GLOBAL MICROARRAY GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.13	GLOBAL NEXT-GENERATION SEQUENCING (NGS) GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.14	GLOBAL GENOME SEQUENCING MARKET SHARE, BY APPLICATION, 2019 & 2026 (USD BILLION)
      FIG.15	GLOBAL DIAGNOSTIC GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.16	GLOBAL RESEARCH GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.17	GLOBAL OTHERS GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.18	GLOBAL GENOME SEQUENCING MARKET SHARE, BY END-USER, 2019 & 2026 (USD BILLION)
      FIG.19	GLOBAL HEALTHCARE FACILITIES & DIAGNOSTIC CENTERS GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.20	GLOBAL RESEARCH INSTITUTES GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.21	GLOBAL PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.22	GLOBAL GENOME SEQUENCING MARKET SHARE, BY REGION, 2019 & 2026 (USD BILLION)
      FIG.23	NORTH AMERICA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.24	U.S. GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.25	CANADA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.26	EUROPE GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.27	GERMANY GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.28	FRANCE GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.29	U.K. GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.30	ITALY GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.31	SPAIN GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.32	REST OF EUROPE GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.33	ASIA PACIFIC GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.34	CHINA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.35	JAPAN GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.36	INDIA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.37	SOUTH  KOREA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.38	SOUTH-EAST ASIA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.39	REST OF ASIA PACIFIC GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.40	LATIN AMERICA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.41	BRAZIL GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.42	MEXICO GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.43	REST OF LATIN AMERICA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.44	THE MIDDLE-EAST AND AFRICA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.45	GCC COUNTRIES GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.46	SOUTH AFRICA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.47	REST OF MIDDLE-EAST AFRICA GENOME SEQUENCING MARKET, 2016 – 2026 (USD BILLION)
      FIG.48	COMPETITOR MARKET SHARE – REVENUE
      FIG.49	ILLUMINA INC. REVENUE AND GROWTH RATE
      FIG.50	ILLUMINA INC. MARKET SHARE
      FIG.51	BGI REVENUE AND GROWTH RATE
      FIG.52	BGI MARKET SHARE
      FIG.53	INTEGRAGEN REVENUE AND GROWTH RATE
      FIG.54	INTEGRAGEN MARKET SHARE
      FIG.55	BIO-RAD LABORATORIES REVENUE AND GROWTH RATE
      FIG.56	BIO-RAD LABORATORIES MARKET SHARE
      FIG.57	QIAGEN REVENUE AND GROWTH RATE
      FIG.58	QIAGEN MARKET SHARE
      FIG.59	DANAHER REVENUE AND GROWTH RATE
      FIG.60	DANAHER MARKET SHARE
      FIG.61	PACIFIC BIOSCIENCES OF CALIFORNIA INC. REVENUE AND GROWTH RATE
      FIG.62	PACIFIC BIOSCIENCES OF CALIFORNIA INC. MARKET SHARE
      FIG.63	OXFORD NANOPORE TECHNOLOGIES REVENUE AND GROWTH RATE
      FIG.64	OXFORD NANOPORE TECHNOLOGIES MARKET SHARE
      FIG.65	GENOME ELECTRIC COMPANY REVENUE AND GROWTH RATE
      FIG.66	GENOME ELECTRIC COMPANY MARKET SHARE
      FIG.67	AGILENT TECHNOLOGIES INC. REVENUE AND GROWTH RATE
      FIG.68	AGILENT TECHNOLOGIES INC. MARKET SHARE
      FIG.69	THERMO FISHER SCIENTIFIC INC. REVENUE AND GROWTH RATE
      FIG.70	THERMO FISHER SCIENTIFIC INC. MARKET SHARE
      FIG.71	F. HOFFMANN-LA ROCHE LTD. REVENUE AND GROWTH RATE
      FIG.72	F. HOFFMANN-LA ROCHE LTD. MARKET SHARE
      FIG.73	MARKET DYNAMICS
      FIG.74	GLOBAL GENOME SEQUENCING – VALUE CHAIN ANALYSIS
      FIG.75	KEY MANDATES AND REGULATIONS
      FIG.76	TECHNOLOGY ROADMAP AND TIMELINE
      FIG.77	MARKET ATTRACTIVENESS ANALYSIS – BY TYPE
      FIG.78	MARKET ATTRACTIVENESS ANALYSIS – BY TECHNOLOGY
      FIG.79	MARKET ATTRACTIVENESS ANALYSIS – BY APPLICATION
      FIG.80	MARKET ATTRACTIVENESS ANALYSIS – BY END-USER
      FIG.81	MARKET ATTRACTIVENESS ANALYSIS – BY REGION
      FIG.82	GENOME SEQUENCING INDUSTRIAL CHAIN ANALYSIS
      FIG.83	MARKET CHANNELS
      FIG.84	MARKETING CHANNEL DEVELOPMENT TREND
      FIG.85	GROWTH IN WORLD GROSS PRODUCT, 2008-2018
      

      List of Tables

      TABLE 1	GLOBAL GENOME SEQUENCING MARKET, 2019 & 2026 (USD BILLION)
      TABLE 2	GLOBAL GENOME SEQUENCING MARKET, BY TYPE, 2016 – 2026 (USD BILLION)
      TABLE 3	GLOBAL GENOME SEQUENCING MARKET, BY TECHNOLOGY, 2016 – 2026 (USD BILLION)
      TABLE 4	GLOBAL GENOME SEQUENCING MARKET, BY APPLICATION, 2016 – 2026 (USD BILLION)
      TABLE 5	GLOBAL GENOME SEQUENCING MARKET, BY END-USER, 2016 – 2026 (USD BILLION)
      TABLE 6	GLOBAL GENOME SEQUENCING MARKET, BY REGION, 2016 – 2026 (USD BILLION)
      TABLE 7	NORTH AMERICA GENOME SEQUENCING MARKET, BY COUNTRY, 2016 – 2026 (USD BILLION)
      TABLE 8	NORTH AMERICA GENOME SEQUENCING MARKET, BY TYPE, 2016 – 2026 (USD BILLION)
      TABLE 9	NORTH AMERICA GENOME SEQUENCING MARKET, BY TECHNOLOGY, 2016 – 2026 (USD BILLION)
      TABLE 10 NORTH AMERICA GENOME SEQUENCING MARKET, BY APPLICATION, 2016 – 2026 (USD BILLION)
      TABLE 11 NORTH AMERICA GENOME SEQUENCING MARKET, BY END-USER, 2016 – 2026 (USD BILLION)
      TABLE 12 EUROPE GENOME SEQUENCING MARKET, BY COUNTRY, 2016 – 2026 (USD BILLION)
      TABLE 13 EUROPE GENOME SEQUENCING MARKET, BY TYPE, 2016 – 2026 (USD BILLION)
      TABLE 14 EUROPE GENOME SEQUENCING MARKET, BY TECHNOLOGY, 2016 – 2026 (USD BILLION)
      TABLE 15 EUROPE GENOME SEQUENCING MARKET, BY APPLICATION, 2016 – 2026 (USD BILLION)
      TABLE 16 EUROPE GENOME SEQUENCING MARKET, BY END-USER, 2016 – 2026 (USD BILLION)
      TABLE 17 ASIA PACIFIC GENOME SEQUENCING MARKET, BY COUNTRY, 2016 – 2026 (USD BILLION)
      TABLE 18 ASIA PACIFIC GENOME SEQUENCING MARKET, BY TYPE, 2016 – 2026 (USD BILLION)
      TABLE 19 ASIA PACIFIC GENOME SEQUENCING MARKET, BY TECHNOLOGY, 2016 – 2026 (USD BILLION)
      TABLE 20 ASIA PACIFIC GENOME SEQUENCING MARKET, BY APPLICATION, 2016 – 2026 (USD BILLION)
      TABLE 21 ASIA PACIFIC GENOME SEQUENCING MARKET, BY END-USER, 2016 – 2026 (USD BILLION)
      TABLE 22 LATIN AMERICA GENOME SEQUENCING MARKET, BY COUNTRY, 2016 – 2026 (USD BILLION)
      TABLE 23 LATIN AMERICA GENOME SEQUENCING MARKET, BY TYPE, 2016 – 2026 (USD BILLION)
      TABLE 24 LATIN AMERICA GENOME SEQUENCING MARKET, BY TECHNOLOGY, 2016 – 2026 (USD BILLION)
      TABLE 25 LATIN AMERICA GENOME SEQUENCING MARKET, BY APPLICATION, 2016 – 2026 (USD BILLION)
      TABLE 26 LATIN AMERICA GENOME SEQUENCING MARKET, BY END-USER, 2016 – 2026 (USD BILLION)
      TABLE 27 THE MIDDLE-EAST AND AFRICA GENOME SEQUENCING MARKET, BY COUNTRY, 2016 – 2026 (USD BILLION)
      TABLE 28 THE MIDDLE-EAST AND AFRICA GENOME SEQUENCING MARKET, BY TYPE, 2016 – 2026 (USD BILLION)
      TABLE 29 THE MIDDLE-EAST AND AFRICA GENOME SEQUENCING MARKET, BY TECHNOLOGY, 2016 – 2026 (USD BILLION)
      TABLE 30 THE MIDDLE-EAST AND AFRICA GENOME SEQUENCING MARKET, BY APPLICATION, 2016 – 2026 (USD BILLION)
      TABLE 31 THE MIDDLE-EAST AND AFRICA GENOME SEQUENCING MARKET, BY END-USER, 2016 – 2026 (USD BILLION)
      TABLE 32 GLOBAL GENOME SEQUENCING MARKET - COMPANY REVENUE ANALYSIS, 2016 – 2019 (USD BILLION)
      TABLE 33 GLOBAL GENOME SEQUENCING MARKET - COMPANY REVENUE SHARE ANALYSIS, 2016 – 2019 (%)
      TABLE 34 ACQUISITIONS AND MERGERS
      TABLE 35 MARKET DRIVERS – IMPACT ANALYSIS
      TABLE 36 MARKET RESTRAINTS
      TABLE 37 MARKET OPPORTUNITIES
      TABLE 38 MAJOR BUYERS OF GENOME SEQUENCING
      TABLE 39 DISTRIBUTORS/TRADERS OF GENOME SEQUENCING BY REGION
      

Covid-19

Genome Sequencing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Illumina Inc.
  • BGI
  • IntegraGen
  • Bio-Rad Laboratories
  • QIAGEN
  • Danaher
  • Pacific Biosciences of California Inc.
  • Oxford Nanopore Technologies
  • Genome Electric Company
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
     

Frequently Asked Questions

The factors propelling the growth of the global genome sequencing market include growing demand for the disease prevention, treatment, and management coupled with the development of new treatments and vaccines.
According to Facts & Factors, global demand for genome sequencing market is expected to generate revenue of around USD 95 Billion by end of 2026, growing at a CAGR of around 20% between 2021 and 2026.
North America is expected to hold the largest market share in global genome sequencing market due to the rising demand for sequencing technologies and personalized medicines in this region.
The key players dominating the global genome sequencing market include Illumina, Inc., BGI, IntegraGen, Bio-Rad Laboratories, QIAGEN, Danaher, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, Genome Electric Company, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd., among others.
why choose fnf
key questions answers

Related Reports

report img

Anesthesia Gas Mixers Market Report 2021 – 2026

Facts Factors recently published a report on theglobal anesthesia gas mixers market. The report encompasses market statistics and analytics. The market value of the anesthesia gas mixers market was witnessed to be USD 500 Million in 2020 and with growth at a CAGR of 6% is projected to reach a val...

Published Date : 28-Dec-2021 | | Category : | Pages : 171 | Format : Read more

Inquiry for Buying Request Sample
report img

Anesthesia Equipment Market Report 2021 – 2026

According to Facts Factors, the report on the Global Anesthesia Equipment Market encompasses the complete history and forecast details. In this report, the market value was witnessed to be around USD 11 Billion in 2020 and with a CAGR of 6.5% will acquire USD 16 Billion by 2026. Report Overview...

Published Date : 28-Dec-2021 | | Category : | Pages : 171 | Format : Read more

Inquiry for Buying Request Sample